Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

359 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The apparent incidence of hip fracture in Europe: a study of national register sources.
Johnell O, Gullberg B, Allander E, Kanis JA; MEDOS Study Group. Johnell O, et al. Osteoporos Int. 1992 Nov;2(6):298-302. doi: 10.1007/BF01623186. Osteoporos Int. 1992. PMID: 1421798
Falls explain between-center differences in the incidence of limb fracture across Europe.
Roy DK, Pye SR, Lunt M, O'Neill TW, Todd C, Raspe H, Reeve J, Silman AJ, Weber K, Dequeker J, Jajic I, Stepan J, Delmas PD, Marchand F, Reisinger W, Banzer D, Felsenberg D, Janott J, Kragl G, Schiedt-Nave C, Felsch B, Raspe H, Matthis C, Lyritis G, Poor G, Gennari C, Pols HA, Falch JA, Miazgowski T, Hoszowski K, Lorenc R, Bruges Armas J, Lopes Vaz A, Benevolenskaya LI, Masaryk P, Rapado A, Cannata JB, Naves-Diaz M, Johnell O, Dilsen G, Reid DM, Bhalla AK, Todd C, Reeve J, Finn JD, Ismail A, Lunt M, O'Neill TW, Pye SR, Roy DK, Kanis JA, Cooper C, Woolf AD; European Prospective Osteoporosis Study (EPOS) Group. Roy DK, et al. Among authors: o neill tw, johnell o. Bone. 2002 Dec;31(6):712-7. doi: 10.1016/s8756-3282(02)00909-2. Bone. 2002. PMID: 12531567
Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group.
Ismail AA, O'Neill TW, Cockerill W, Finn JD, Cannata JB, Hoszowski K, Johnell O, Matthis C, Raspe H, Raspe A, Reeve J, Silman AJ. Ismail AA, et al. Among authors: o neill tw, johnell o. Osteoporos Int. 2000;11(3):248-54. doi: 10.1007/s001980050288. Osteoporos Int. 2000. PMID: 10824241
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis.
Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O, Kanis JA, Kellingray S, Leplege A, Liberman UA, McCloskey E, Minne H, Reeve J, Reginster JY, Scholz M, Todd C, de Vernejoul MC, Wiklund I. Lips P, et al. Among authors: johnell o. Osteoporos Int. 1999;10(2):150-60. doi: 10.1007/s001980050210. Osteoporos Int. 1999. PMID: 10501796
BMD, clinical risk factors and their combination for hip fracture prevention.
Johansson H, Kanis JA, Oden A, Johnell O, McCloskey E. Johansson H, et al. Among authors: johnell o. Osteoporos Int. 2009 Oct;20(10):1675-82. doi: 10.1007/s00198-009-0845-x. Epub 2009 Mar 17. Osteoporos Int. 2009. PMID: 19291344
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries--an economic evaluation based on the fracture intervention trial.
Ström O, Borgström F, Sen SS, Boonen S, Haentjens P, Johnell O, Kanis JA. Ström O, et al. Among authors: johnell o. Osteoporos Int. 2007 Aug;18(8):1047-61. doi: 10.1007/s00198-007-0349-5. Epub 2007 Feb 28. Osteoporos Int. 2007. PMID: 17333449
Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study.
Kaptoge S, Armbrecht G, Felsenberg D, Lunt M, Weber K, Boonen S, Jajic I, Stepan JJ, Banzer D, Reisinger W, Janott J, Kragl G, Scheidt-Nave C, Felsch B, Matthis C, Raspe HH, Lyritis G, Póor G, Nuti R, Miazgowski T, Hoszowski K, Armas JB, Vaz AL, Benevolenskaya LI, Masaryk P, Cannata JB, Johnell O, Reid DM, Bhalla A, Woolf AD, Todd CJ, Cooper C, Eastell R, Kanis JA, O'Neill TW, Silman AJ, Reeve J. Kaptoge S, et al. Among authors: johnell o, o neill tw. Osteoporos Int. 2006;17(9):1369-81. doi: 10.1007/s00198-005-0067-9. Epub 2006 Jul 5. Osteoporos Int. 2006. PMID: 16821002
The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective.
Borgström F, Carlsson A, Sintonen H, Boonen S, Haentjens P, Burge R, Johnell O, Jönsson B, Kanis JA. Borgström F, et al. Among authors: johnell o. Osteoporos Int. 2006;17(7):996-1007. doi: 10.1007/s00198-006-0094-1. Epub 2006 Mar 29. Osteoporos Int. 2006. PMID: 16570118
Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women.
Lundkvist J, Johnell O, Cooper C, Sykes D. Lundkvist J, et al. Among authors: johnell o. Osteoporos Int. 2006 Feb;17(2):201-11. doi: 10.1007/s00198-005-1959-4. Epub 2005 Jul 19. Osteoporos Int. 2006. PMID: 16027955
Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study.
Kanis JA, Borgström F, Johnell O, Oden A, Sykes D, Jönsson B. Kanis JA, et al. Among authors: johnell o. Osteoporos Int. 2005 Jan;16(1):15-25. doi: 10.1007/s00198-004-1688-0. Epub 2004 Jul 24. Osteoporos Int. 2005. PMID: 15672210 Clinical Trial.
359 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback